🇺🇸 FDA

Intelligence · Patent portfolio

Acadia Pharmaceuticals Patents

Full USPTO pharma patent portfolio for Acadia Pharmaceuticals — grant dates, expiration, and drug cross-links.

Patents
77
Expiring ≤24m
9

Quick answer

Acadia Pharmaceuticals has 77 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 9 expire within 24 months — use filters for patent-cliff planning.

Page 2 of 2

  1. US 7622461

    Amino substituted diaryl[a,d]cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disorders

    Expires Mon Nov 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 7601740

    Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases

    Expires Mon Oct 08 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 7585877

    Aminophenyl derivatives as selective androgen receptor modulators

    Expires Mon Sep 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 7576100

    Muscarinic agonists

    Expires Mon Aug 13 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 7576078

    Tetrahydroquinoline analogues as muscarinic agonists

    Expires Mon Aug 13 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 7550454

    Amino substituted diaryl[a,d]cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disorders

    Expires Mon Jun 18 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 7550459

    Tetrahydroquinoline analogues as muscarinic agonists

    Expires Mon Jun 18 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 7517871

    Amino substituted diaryl[a,d]cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disorders

    Expires Mon Apr 09 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 7511053

    Spiroazacyclic compounds as monoamine receptor modulators

    Expires Mon Mar 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 7491715

    Amino substituted diaryl[a,d]cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disorders

    Expires Mon Feb 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 7485651

    Compounds with activity on muscarinic receptors

    Expires Mon Jan 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 7476682

    N-substituted piperidine derivatives as serotonin receptor agents

    Expires Mon Jan 08 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 7402590

    Spiroazacyclic compounds as monoamine receptor modulators

    Expires Mon Jul 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 7351707

    Spiroazacyclic compounds as monoamine receptor modulators

    Expires Mon Mar 27 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 7307075

    Tetrahydroquinoline analogues as muscarinic agonists

    Expires Mon Dec 06 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 7300928

    Benzimidazolidinone derivatives as muscarinic agents

    Expires Mon Nov 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 7291611

    Benzimidazolidinone derivatives as muscarinic agents

    Expires Mon Nov 01 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 7273857

    Benzimidazolidinone derivatives as muscarinic agents

    Expires Mon Sep 20 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 7268232

    Androgen receptor modulators and method of treating disease using the same

    Expires Mon Sep 06 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 7238713

    Muscarinic agonists

    Expires Mon Jun 28 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 7217719

    Spiroazacyclic compounds as monoamine receptor modulators

    Expires Mon May 10 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 7087593

    Benzimidazolidinone derivatives as muscarinic agents

    Expires Mon Aug 03 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 6951849

    Benzimidazolidinone derivatives as muscarinic agents

    Expires Mon Sep 29 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  24. US 6911452

    Spiroazacyclic compounds as monoamine receptor modulators

    Expires Mon Jun 23 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  25. US 6815458

    Azacyclic compounds

    Expires Mon Nov 04 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  26. US 6756393

    Azacyclic compounds

    Expires Mon Jun 24 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  27. US 6627645

    Muscarinic agonists

    Expires Mon Sep 25 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  28. US 6528529

    Compounds with activity on muscarinic receptors

    Expires Mon Feb 27 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  29. US 6358698

    Methods of identifying inverse agonists of the serotonin 2A receptor

    Expires Mon Mar 14 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

How many patents does Acadia Pharmaceuticals have?

77 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Acadia Pharmaceuticals patents expire?

9 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.